Paper29326488
Resveratrol prevents liver fibrosis via two possible pathways: Modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses.
Hessin AF and 4 others. Indian J Pharmacol, 2017. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Resveratrol prevents liver fibrosis via two possible pathways: Modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses. Papers, record 29326488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29326488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Resveratrol prevents liver fibrosis via two possible pathways: Modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antioxidants | Major topic |
| Liver Cirrhosis | Major topic |
| Protein Kinase C | Major topic |
| Stilbenes | Major topic |
| alpha-Fetoproteins | Major topic |
| Animals | |
| Male | |
| Oxidative Stress | |
| Rats | |
| Rats, Wistar | |
| Resveratrol |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26159266 | Hepatic Fibrosis: Emerging Therapies. | Dig Dis | 2015 | https://conductscience.org/library/papers/26159266 | PubMed |
| 2 | 26530037 | Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways. | Mol Med Rep | 2016 | https://conductscience.org/library/papers/26530037 | PubMed |
| 3 | 22626794 | Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches. | Saudi J Gastroenterol | 2012 | https://conductscience.org/library/papers/22626794 | PubMed |
| 4 | 14661062 | Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. | Oncogene | 2004 | https://conductscience.org/library/papers/14661062 | PubMed |
| 5 | 25974898 | Resolution of liver fibrosis: basic mechanisms and clinical relevance. | Semin Liver Dis | 2015 | https://conductscience.org/library/papers/25974898 | PubMed |
| 6 | 13786180 | The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. | Arch Biochem Biophys | 1961 | https://conductscience.org/library/papers/13786180 | PubMed |
| 7 | 23997791 | Mechanism of Hepatoprotective Effect of Boesenbergia rotunda in Thioacetamide-Induced Liver Damage in Rats. | Evid Based Complement Alternat Med | 2013 | https://conductscience.org/library/papers/23997791 | PubMed |
| 8 | 11172339 | Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats. | Hepatology | 2001 | https://conductscience.org/library/papers/11172339 | PubMed |
| 9 | 25869468 | Recent advancement of molecular mechanisms of liver fibrosis. | J Hepatobiliary Pancreat Sci | 2015 | https://conductscience.org/library/papers/25869468 | PubMed |
| 10 | 23762157 | Hepatoprotective Role of Ethanolic Extract of Vitex negundo in Thioacetamide-Induced Liver Fibrosis in Male Rats. | Evid Based Complement Alternat Med | 2013 | https://conductscience.org/library/papers/23762157 | PubMed |
| 11 | 25064540 | Resveratrol mitigate structural changes and hepatic stellate cell activation in N'-nitrosodimethylamine-induced liver fibrosis via restraining oxidative damage. | Chem Biol Interact | 2014 | https://conductscience.org/library/papers/25064540 | PubMed |
| 12 | 28959665 | Anti-inflammatory and antioxidant role of resveratrol on nicotine-induced lung changes in male rats. | Toxicol Rep | 2017 | https://conductscience.org/library/papers/28959665 | PubMed |
| 13 | 21647311 | Hepatoprotective Effects of Orthosiphon stamineus Extract on Thioacetamide-Induced Liver Cirrhosis in Rats. | Evid Based Complement Alternat Med | 2011 | https://conductscience.org/library/papers/21647311 | PubMed |
| 14 | 23411180 | Pterostilbene inhibits dimethylnitrosamine-induced liver fibrosis in rats. | Food Chem | 2013 | https://conductscience.org/library/papers/23411180 | PubMed |
| 15 | 25311610 | Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. | Nutr Res | 2014 | https://conductscience.org/library/papers/25311610 | PubMed |
| 16 | 22776464 | Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function. | Cell Transplant | 2012 | https://conductscience.org/library/papers/22776464 | PubMed |
| 17 | 10924854 | Protein kinase C signaling and oxidative stress. | Free Radic Biol Med | 2000 | https://conductscience.org/library/papers/10924854 | PubMed |
| 18 | 26742567 | Resveratrol can prevent CCl₄-induced liver injury by inhibiting Notch signaling pathway. | Histol Histopathol | 2016 | https://conductscience.org/library/papers/26742567 | PubMed |
| 19 | 25633908 | Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. | Health Technol Assess | 2015 | https://conductscience.org/library/papers/25633908 | PubMed |
| 20 | 17879097 | Kinetics of albumin- and alpha-fetoprotein-production during rat liver development. | Histochem Cell Biol | 2007 | https://conductscience.org/library/papers/17879097 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41049375 | The efficacy of resveratrol in the treatment of liver fibrosis: a systematic review and meta-analysis of preclinical studies. | Front Nutr | 2025 | https://conductscience.org/library/papers/41049375 | PubMed |
| 38214394 | Nrf2/HO-1, NF-κB and PI3K/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38214394 | PubMed |
| 38067665 | Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. | Molecules | 2023 | https://conductscience.org/library/papers/38067665 | PubMed |
| 36825158 | Protective role of resveratrol against VCM-induced hepatotoxicity in male wistar rats. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36825158 | PubMed |
| 36358524 | Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36358524 | PubMed |
| 35912113 | Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35912113 | PubMed |
| 35698613 | Resveratrol ameliorates iron overload induced liver fibrosis in mice by regulating iron homeostasis. | PeerJ | 2022 | https://conductscience.org/library/papers/35698613 | PubMed |
| 35508992 | Resveratrol ameliorates liver fibrosis induced by nonpathogenic Staphylococcus in BALB/c mice through inhibiting its growth. | Mol Med | 2022 | https://conductscience.org/library/papers/35508992 | PubMed |
| 34965258 | The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats. | PLoS One | 2021 | https://conductscience.org/library/papers/34965258 | PubMed |
| 33805795 | The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials. | Nutrients | 2021 | https://conductscience.org/library/papers/33805795 | PubMed |
| 33125088 | Resveratrol contributes to the inhibition of liver fibrosis by inducing autophagy via the microRNA‑20a‑mediated activation of the PTEN/PI3K/AKT signaling pathway. | Int J Mol Med | 2020 | https://conductscience.org/library/papers/33125088 | PubMed |
| 33082829 | A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids. | Evid Based Complement Alternat Med | 2020 | https://conductscience.org/library/papers/33082829 | PubMed |
| 32647690 | Polydatin relieves paraquat-induced human MRC-5 fibroblast injury through inhibiting the activation of the NLRP3 inflammasome. | Ann Transl Med | 2020 | https://conductscience.org/library/papers/32647690 | PubMed |
| 32389821 | Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis. | Biomed J | 2021 | https://conductscience.org/library/papers/32389821 | PubMed |
| 29785090 | Semen Brassicae ameliorates hepatic fibrosis by regulating transforming growth factor-β1/Smad, nuclear factor-κB, and AKT signaling pathways in rats. | Drug Des Devel Ther | 2018 | https://conductscience.org/library/papers/29785090 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| PRRT2 | 112476 | PubTator's text mining | https://conductscience.org/library/genes/112476 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29326488
GET https://conductscience.org/api/papers/v1/29326488/references?page=2